Reactivation of Chronic Hepatitis C Virus Infection by Immunoadsorption in Factor VIII Inhibitor Haemophilia

Franz Rommel; Marcell Toepfer; Josef Eberle; Helmut Schiffl; Michael Spannagl; Wolfgang Schramm

doi:10.1055/s-0037-1614101

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2000; 84(04): 733-734
DOI: 10.1055/s-0037-1614101

Letters to the Editor

Schattauer GmbH

Reactivation of Chronic Hepatitis C Virus Infection by Immunoadsorption in Factor VIII Inhibitor Haemophilia

Franz Rommel

²From the Division of Haematology, Medizinische Klinik Innenstadt

,

Marcell Toepfer

²From the Division of Haematology, Medizinische Klinik Innenstadt

,

Josef Eberle

¹Max-von-Pettenkofer-Institut, Ludwig-Maximilians-University, Munich, Germany

,

Helmut Schiffl

²From the Division of Haematology, Medizinische Klinik Innenstadt

,

Michael Spannagl

²From the Division of Haematology, Medizinische Klinik Innenstadt

,

Wolfgang Schramm

²From the Division of Haematology, Medizinische Klinik Innenstadt

› Author Affiliations

Abstract

Full Text

References

References
1 Freiburghaus C, Berntrop E, Ekman M, Gunnarson M, Kjellberg BM, Nilsson IM. Immunoadsorption for removal of inhibitors: update on treatments in Malmo-Lund between 1980 and 1995. Hemophilia 1998; 04: 16-20.
2 Knöbl P, Derfler K, Korninger L, Kapiotis S, Jäger U, Maier-Dobersberger T, Hörl W, Lechner K, Pabinger I. Elimination of aquirded factor VIII antibodies by exrtacorporeal antibody-based immunoadsorption (Ig-Thera sorb). Thromb Haemost 1995; 74: 1035-8.
3 Nilsson IM, Freiburghaus C. Apheresis. Adv Exp Med Biol 1995; 386: 175-84.
4 Freedman J, Semple JW, Teitel J, Stewart K, Garvey B. Clinical and immunologic effects of staphylococcal protein A immunoadsorption therapy for inhibitor of factor VIII. Transfus Sci 1992; 13: 223-8.
5 Moulin A, Muller-Derlich J, Bieber F, Richter WO, Frei U, Muller R, Spaethe R. Antibody-based immunoadsorption as a therapeutic means. Blood Purif 1993; 11: 145-9.
6 Richter WO, Donner MG, Selmaier A, Hiller E, Schwandt P. Efficacy and safety of immunoglobulin apheresis. ASAIO J 1997; 43: 53-9.
7 Calleja JL, Albillos A, Cacho G, Iborra J, Abreu L, Escartin P. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies. J Hepatol 1996; 24: 308-12.
8 Thiele DL, DuCharme L, Cunningham MR, Mimms LT, Cuthbert JA, Lee WM, Combes B. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients. Am J Gastroenterol 1996; 91: 300-8.
9 Bjorkander J, Cunningham CRundles, Lundin P, Olsson R, Soderstrom R, Hanson LA. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med 1988; 84: 107-11.
10 Zeldis JB, Jensen P. Hepatitis C virus pathogenicity: the corner pieces of the jigsaw puzzle are found. Gastroenterology 1994; 106: 1118-20.